Extracellular hemoglobin (Hb) has multiple biological activities that can initiate and exacerbate disease processes. 1 In acquired and genetic hemolytic anemias, malaria, massive blood transfusions, and severe infections, the presence of free Hb appears to cause endothelial dysfunction, vascular damage, and inflammation. 2 More-localized effects of extracellular Hb are relevant during the initiation and propagation of atherosclerosis and in the regulation of inflammation and wound healing. 3, 4 During mild hemolysis, Hb and heme scavenger plasma proteins attenuate the adverse effects of extracellular Hb.
1 Haptoglobin (Hp) binds extracellular Hb to form an irreversible complex that can be cleared by CD163-positive monocytes and macrophages. 5, 6, 7 Preclinical studies have suggested a strong therapeutic potential for Hp infusion in conditions with enhanced intravascular hemolysis. 8, 9 Within the Hb/Hp complex, the inherent vasoactivity of free Hb remains controlled, its redox reactivity is stabilized, and Hb itself is protected against oxidative damage.
8,10,11
On a molecular level, the pathophysiology of Hb is generally explained by its side reactions. 1 Among these reactions, depletion of the vasodilator nitric oxide (NO) and its reaction with hydrogen peroxide (H 2 O 2 ) are the most extensively studied. H 2 O 2 is produced by nicotinamide adenine dinucleotide phosphate oxidases at supra-physiological levels upon tissue damage by resident tissue cells (i.e., epithelial cells) and during the subsequent inflammatory reaction by invading leukocytes. 12, 13, 14 However, although NO depletion and associated endothelial dysfunction is now an accepted pathophysiologic model, a set of cohesive mechanistic concepts that link the oxidative side reactions of Hb to adverse cellular and physiologic responses is still lacking. Specifically, gaps in our knowledge remain concerning the mechanisms that link the primary biochemical processes (i.e., the reactions of Hb with H 2 O 2 ) with the reaction intermediates, final effectors, and pathways that ultimately determine cellular-and tissue-level damage. Accordingly, the mechanisms by which Hp could protect against oxidative Hb toxicity are not clear. The current theories causally relate oxidative Hb toxicity and Hp protection to diverse mechanisms even in the absence of strong biological evidence. 11, 15, 16, 17, 18, 19, 20 In this study, we utilized a systematic approach to characterize Hp-attenuated reaction species that could mediate 'oxidative' toxicity of Hb to endothelial cells. The toxic species identified include primary globin denaturation products and secondary lipoprotein peroxidation products, both of which result from the continuous reactions of Hb with physiological levels of H 2 O 2 .
Our results suggest that the anti-oxidative function of Hp against endothelium-directed Hb toxicity is based primarily on two activities. First, Hp stabilizes the protein structure of Hb itself, thus preventing unfolding and aggregation of the protein, and second, Hp halts heme and/or radical transfer from Hb to reactive lipoproteins. Importantly, this caging effect of Hp allows the Hb/Hp complex to function as a protective sink for reactive oxygen species within Hb-and H 2 O 2 -exposed tissues.
Results
Hb degradation products are an Hp-attenuated mediator of endothelial damage. We incubated human endothelial cells with human Hb (Fe 2 þ , 2 mg/ml) and a low level of the H 2 O 2 -generating enzyme glucose oxidase (GOX; 2.5 mU/ml) to simulate the conditions of concurrent extracellular Hb exposure and oxidative stress ( Figure 1 ). Low activities of GOX in cell culture medium have been found to mimic levels of H 2 O 2 produced by stimulated neutrophil granulocytes. 14 Electrical endothelial resistance was measured as a functional surrogate marker of endothelial damage. Combined treatment with human Hb and GOX resulted in a rapid decrease in endothelial resistance that occurred within hours of the onset of the incubation period. Figure 1a shows representative experiments for human umbilical vein endothelial cells (HUVECs) and human pulmonary artery endothelial cells (HPAECs); comparable results were obtained with human lung microvascular endothelial cells (HLMVECs) and human lymphatic endothelial cells (HLyECs) in preliminary studies (data not shown). This decrease in endothelial electrical resistance was accompanied by the redistribution of the adherens junction protein b-catenin and ultrastructural evidence of intercellular gap formation in regions with decreased b-catenin staining (Figure 1b) . In contrast, when applied alone, even prolonged incubations with either human Hb or GOX did not induce any measurable changes in cell function or morphology. The GOX activity used in these studies has been shown to generate steady-state H 2 O 2 levels in the range of 5-20 mM in cell culture, which is in a low supra-physiologic range observed acutely after wounding. 12, 21, 22 Gene array analysis confirmed that the low level of H 2 O 2 generated in this model induced only minimal changes in overall gene expression that were not indicative of oxidative stress or cell damage (Supplementary Figure 1) .
The human Hb þ GOX-induced damage in HPAEC (Figure 1c ) was completely prevented by the addition of purified human Hp (2 mg/ml). Identical protection was also found for other endothelial cell types (HPAEC, HLMVEC, and HLyEC; data not shown).
Our earlier studies suggested that Hb bound to Hp in the Hb/ Hp complex can still react with H 2 O 2 , but the structure of the Hb/Hp complex remains protected from oxidative damage and denaturation. 23 In contrast, in the absence of Hp, free Hb is extensively oxidized at specific amino-acid sites leading to structural destabilization of the protein with subsequent denaturation, covalent protein cross-linking, and aggregation. 24, 25, 26 Therefore, we speculated that the toxicity that occurs in our model in the absence of Hp may be induced by such Hb denaturation and aggregation products. To test this hypothesis, we probed our cell culture system with two types of Hb that are more resistant to oxidative protein degradation by H 2 O 2 . These proteins were (1) a-a-cross-linked human Hb (aXLHb). This Hb is a tetrameric Hb, which is stabilized by the chemical cross-linker bis(3,5-dibromosalicyl)fumarate (DBBF), and (2) bovine Hb (bvHb), which is a dissociable tetramer with an enhanced conformational stability because of its specific amino-acid sequence. Aggregation that could occur upon unfolding of the different Hbs as well as of the Hb/Hp complex during H 2 O 2 reactions can be monitored by spectrophotometry. As shown in Figure 2a , aggregate formation can be observed with native human Hb but not with aXLHb, bvHb, or the Hb/Hp complex. In strong correlation with the absent aggregate formation, the oxidation of the structurally stabilized Hbs was not associated with endothelial damage (Figure 2b ). The generation of Hb denaturation products with the unstable human Hb could also be observed in cell culture by scanning electron microscopy (SEM; Figure 2c ). We found extensive aggregate endothelial cell interactions with engulfment of the nanometer-to micrometersized particles by HPAECs (Figure 2d ). Therefore, we assumed that one mechanism of oxidative Hb toxicity is directly related to the appearance of these Hb denaturation/ aggregation products that have the ability to initiate endothelial cell damage (mechanism 1 in Figure 7 ).
The intrinsic Hb oxidation pathway generates toxic reaction products that are attenuated by Hp. To conclusively dissect the biological impact of the different Hb oxidation products, we biochemically characterized the H 2 O 2 reactions of all evaluated types of Hb and correlated the generation of different oxidation products with the observed biological responses of endothelial cells. Under identical conditions as in our cell culture experiments (i.e., 37 1C and complete endothelial cell culture medium), Hb heme-iron oxidation with production of HbFe 3 þ and HbFe 4 þ was similar for human Hb, aXLHb, bvHb, and the Hb/Hp complex ( Figure 3a) . Heme release was slightly reduced with bvHb and aXLHb, but only the Hb/Hp complex completely prevented heme transfer from ferric Hb to hemopexin (Hpx; Figures 3b and c) . EPR-detectable 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline-N-oxide (DEPMPO) radicals were highest with the Hb/Hp complex, which is compatible with a radical-stabilizing function of Hp. 11 Human Hb, aXLHb, and bvHb all led to similar levels of free radical production ( Figure 3d) . In this first model, it is likely that the Hb degradation products, which are unique for the H 2 O 2 reaction with the human Hb, are the toxic species. Generation of the primary heme-iron oxidation products (Hb-Fe 3 þ and Hb-Fe 4 þ ), DEPMPO-trappable radicals, and free heme are common among all reactions that occurred in the toxic as well as in the nontoxic conditions. These species could therefore be excluded as the ultimate mediators of toxicity.
The extrinsic Hb oxidation pathway generates toxic lipid oxidation products in the absence of Hp. To evaluate the role of Hb reactions with extrinsic (non-Hb) molecules, we supplemented our cell culture model by adding human plasma-derived low-density lipoprotein (LDL) as a potential substrate of Hb's peroxidative activity. The addition of 0.5 mg/ml LDL to the Hb-H 2 O 2 reaction led to a cytotoxic endothelial response with loss of electric monolayer resistance (Figures 4b and c) . This endothelial damage mechanism was independent of Hb's intrinsic structural stability and did occur with human Hb, bvHb (Figure 4b two principal oxidative Hb reaction pathways can be discriminated. An intrinsic oxidation pathway generates Hb degradation products, whereas an extrinsic oxidation pathway generates secondary lipid oxidation products. Both of them can eventually lead to endothelial damage and both are attenuated by Hp ( Figure 7 ). Further evidence for the discriminative nature of these two mechanisms could be provided if unique cellular responses could be defined that are specifically triggered by these two reactions. Therefore, we characterized the messenger ribonucleic acid (mRNA) expression profile of HPAECs in response to the two toxic reactions by gene array analysis ( Figure 5 ). Figure 5a summarizes the reaction products that are generated during the different toxic and nontoxic incubation conditions and which eventually could stimulate transcriptional responses in endothelial cells. Figure 5b shows a principal component analysis (PCA) of the global mRNA transcriptome changes triggered by the different treatments. The PCA shows that the individual experimental samples cluster within three distinct groups. Within the first group (multiple colors) we find the control samples, as well as the samples that were exposed to the previously defined nontoxic Hb reactions. Specifically, within this group we identified the samples that were only treated with Hb (Fe 2 þ ) as well as the samples treated with the structurally stable bvHb þ GOX where redox cycling (Fe 3 þ /Fe 4 þ formation) as well as heme release and radical production (but not globin degradation or LDL oxidation) do occur. These data confirm that in this model radical generation, ferric and ferryl Hb formation and heme release are not the immediate inducers of the adverse endothelial response. In contrast, the transcriptome profile of the samples treated with the unstable human Hb þ GOX (green) and samples exposed to bvHb þ LDL þ GOX (brown) clearly separated from each other and from all other conditions.
To extract meaningful gene signatures that may better define the apparently dichotomous adverse cellular responses, we have selected all genes that were differently expressed in any of the five tested conditions. The level of selection stringency was set at greater than twofold upregulation compared with control cells at FDR 0.05 (ANOVA). The 2046 genes that met these inclusion criteria served as an input data set for the hierarchical two-way clustering analysis shown in Figure 5c . As expected from the PCA, the samples treated with 'nontoxic' conditions do not separate from each other and it is not reasonable to extract characteristic gene clusters or expression patterns for any of these treatments, underpinning the minimal impact of the 'common' Hb reaction products on the endothelium. However, the samples treated with bvHb þ LDL þ GOX and those treated with human Hb þ GOX clustered in two distinct groups were clearly discriminated from each other by non-overlapping gene signatures (see also Supplementary Excel Table for more detailed data).
A functional analysis of the exposure-specific gene clusters was performed with a comparative Metacore (Thomson Reuters, New York, NY, USA) network analysis. The top 10 significantly enriched functional networks for each condition are shown in Figure 5d . The response of cells treated with bvHb þ LDL þ GOX (gene cluster A) is characterized by upregulation of heat shock proteins (e.g., heat shock protein 70) and activating transcription factor 3 (ATF3), which is a known stress-inducible transcription factor. 27 In contrast, the human Hb aggregates evoke a paramount inflammatory response with the adhesion molecule E-Selectin (SELE) as the most upregulated signature gene (gene cluster B; see also Supplementary Excel Table and Supplementary Figure 3 for more detailed data). The white color appearance of the Hb precipitates on the front section of the 3D image is indicative of the high density of these particles that allowed automatic recognition and reconstruction by the image processing software (Imaris Software), which clearly show internalized particles as well as particle aggregates on the surface of the cell
The apparent dichotomy of the cellular responses to the Hb aggregates and the oxidized LDL, respectively, can also be illustrated by a morphological analysis of adherence junction (b-catenin) and cytoskeleton (actin) morphology (Supplementary Figure 2) .
The shielded pseudoperoxidase activity of Hb within the Hb/Hp complex can protect endothelial cells against peroxidative damage. Formation of the Hb/Hp complex does not change the pseudoperoxidase (H 2 O 2 -consuming) activity of Hb. Therefore, as an ultimate effect, Hp protection could imply that this pseudoperoxidase activity could represent a novel antioxidant function of the complex. 23, 26, 28 To test this hypothesis, we adjusted our cell culture system to mimic conditions of toxic H 2 O 2 exposure (Figure 6 ). The amount of H 2 O 2 generated in situ by 20 mU/ml GOX (high GOX) is estimated to produce H 2 O 2 steady-state levels in high supra-physiologic range (50-100 mM) and induced endothelial cell damage. 21 Specifically, redistribution/ disappearance of the adherens junction protein b-catenin and a decrease in transendothelial resistance could be observed within hours (Figures 6a and c) . In accordance with our previous experiments, endothelial damage appeared to even be amplified when free huHb was added to the H 2 O 2 -generating system and, consequently, toxic denaturation products were formed (Figure 6c) . However, the gene expression analysis shown in Figure 6b suggested that Hb switches the cellular mechanism of H 2 O 2 -mediated damage from oxidative stress to inflammation. In agreement with the H 2 O 2 -consuming activity of Hb, the H 2 O 2 -associated gene cluster (gene cluster A) was normalized when extracellular Hb was present in the treatment. The top upregulated gene within this H 2 O 2 signature cluster is the stress-signaling transcription factor ATF3 (Supplementary Excel file). 27 In contrast, the new gene cluster that appeared when Hb was added to the oxidative system represents inflammation (gene cluster B). The Hb-mediated switch from oxidative stress to inflammation could be confirmed by quantitative real-time polymerase chain reaction (RT-PCR) as a clear switch of high ATF-3 -high SELE gene expression (Figure 6d ).
Supplementary Figure 3 illustrates the validation of our array gene expression data with TaqMan real-time PCR for 15 genes that represent the oxidative stress (a) and inflammatory (b) gene clusters shown in Figures 6b. For all genes, we found congruent expression patterns between gene array and PCR analysis, with a strong overall correlation between the two methods (Pearson r 2 ¼ 0.85; Po0.0001). The shielded Hb/Hp complex prevented both pathways of endothelial damage and attenuated all associated gene expression changes.
Discussion
In a standardized cell culture model of concurrent Hb exposure and oxidative stress, we defined Hp-attenuated mechanisms by which Hb oxidation could damage the endothelium. Two primary mechanisms could be defined ( Figure 7 ). The first mechanism involves Hb denaturation products that trigger a strong inflammatory response, whereas the second mechanism involves a cytotoxic reaction induced by oxidatively transformed bystander molecules (i.e., LDL). Hp stabilizes the Hb structure (preventing mechanism 1) and shields the environment from Hb-catalyzed oxidation (preventing mechanism 2). These unique protective functions of Hp indicate an unrecognized biological role of the Hb/Hp complex. Within the complex, the pseudoperoxidase activity of Hb is switched from a destructive to a protective reaction, which may ultimately help to preserve cell integrity during peroxidative stress.
Our in vitro model is conceptually based on a correlative analysis of (1) diverse cellular responses upon in situ oxidative reactions of different types of Hb and (2) common and divergent structure and reaction properties of these types of Hb in addition to the Hb/Hp complex.
When endothelial cells were exposed to human Hb in the presence of a nontoxic concentration of GOX, we observed a decrease in transendothelial resistance, a loss of adherens junction organization, and subsequently, a robust inflammatory response. This response was observed in experiments with several endothelial cell types and was completely prevented by the presence of Hp. In contrast to the experiments with human Hb, inflammatory responses, and cell damage were not observed when endothelial cells were exposed to the same peroxidative conditions in the presence of structure-stable Hbs. These results lead to the following questions: (1) What are the differences between the 'toxic' and 'nontoxic' types of Hb that could explain such a divergent biologic response? (2) Could this observation explain a mechanism whereby Hp could act as a protective Hb-binding protein?
The types of Hb in this study are very similar. Human Hb and aXLHb have the exact same peptide sequence and comparable quaternary structures and differ only in a defined chemical cross-linker that provides enhanced structural stability to aXLHb. 10 BvHb is a dissociable tetramer with enhanced protein stability to pro-oxidants because of differences in the amino-acid sequence that have accumulated Figure 6 The Hb/Hp complex is a protective sink for cytotoxic extracellular H 2 O 2 . High-dose H 2 O 2 -mediated endothelial cell toxicity was mimicked by treating confluent HUVEC endothelial monolayers with 20 mU/ml GOX (high GOX). (a) b-Catenin (red) immunofluorescence of endothelial cells incubated with high GOX, high GOX þ huHb, or high GOX þ Hb/Hp (blue ¼ DAPI-stained nuclei, original magnification Â 630). (b) Global gene expression changes observed after 8 h with the treatments indicated on the top of the graph. The heat-map shows the result of a hierarchical clustering of the most significantly upregulated (red) and downregulated (blue) genes (compared with untreated controls). While there appeared to be almost no significant gene expression changes after high GOX þ Hb/Hp treatment, distinct and mutually exclusive clusters of highly regulated genes appeared after treatment with either high GOX alone (-oxidative stress) or high GOX þ huHb (-inflammation). (c) The breakdown of electrical resistance observed during high GOX treatment (red line) was exaggerated when huHb (2 mg/ml) was added to the system (blue line) and completely halted by the addition of Hb/Hp (2 mg/ml) (grey line). (d) RT-PCR confirmation of the representative signature genes of the oxidative stress response (ATF3), which was induced by high GOX alone, and inflammation (SELE), which was only induced by high GOX þ Hb. Hp attenuates both responses to control levels (date are presented as mean±S.D. of three independent experiments) toxicity. We could also disqualify dissociated free heme as the ultimate mediator of cellular damage in this system as it is released from all types of Hb in the absence of Hp. Presumably, free heme did not exceed the threshold for toxicity in our model. In addition, the endothelial cells were likely protected from heme-mediated cytotoxicity by the presence of plasma proteins in the cell culture medium as well as by a strong baseline heme oxygenase 1 (HO-1) expression that was further enhanced during oxidative Hb stress. Rather, the role of free heme in our model concerns its ability to enhance oxidative modification of bystander molecules (if present). 1, 29 In a previously published study, we also demonstrated that similar patterns and quantities of primary globin amino-acid oxidation end-products (i.e., formation of cysteic acid at position bCys93) occurred during oxidation of native human and aXLHb. 30 Collectively, we can exclude the primary heme-oxidized Hb species (ferric Hb 3 þ or ferryl Hb 4 þ ), free heme, Hb oxidationderived free radicals, and secondary globin amino oxidation products as being the immediate pro-inflammatory and cytotoxic compounds that emerge during Hb peroxidation.
Hb is prone to complex oxidation-driven structural modifications, such as loss of a-helical structure, covalent globin cross-linking, polymerization, and aggregation. 24, 25 These Hb polymers/aggregates were the only reaction products that we found to occur with the toxic native human Hb but not with the two structure-stable Hbs. Endothelial cells extensively interacted with and internalized these degradation products before intercellular gaps, inflammation, and overt cellular damage could be observed. Therefore, as all the other considered reaction intermediates were the same among the three types of Hb, it is likely that these Hb degradation products triggered the adverse endothelial response. A similar process may also explain the toxicity of Hb that was oxidatively damaged by the bolus addition of H 2 O 2, as reported by the Soares group. 31 In our earlier work, we demonstrated biochemical evidence that Hp can stabilize the protein structure of Hb and that this stabilization is essential for the effective recognition of the complex by the macrophage Hb scavenger receptor CD163. 23 The model presented in this paper allows us to now, for the first time, relate this Hb-stabilizing activity of Hp to a strong anti-oxidative protective function within a biological system.
In an extended model that contained extrinsic reactive molecules that could be modified by Hb's peroxidative reactivity, we could confirm that Hb-catalyzed oxidative reactions also generate toxic non-globin products. In this model, the external 'mediator molecule' (LDL) bears the primary impact of the free radical reactivity and is thereby transformed into a toxic compound (i.e., oxLDL). This mechanism of Hb toxicity is independent of globin stability and is in agreement with numerous earlier studies that explored the lipid-peroxidative properties of free heme and Hb, particularly in the context of atherosclerosis. 29, 32, 33 The discriminating gene expression responses triggered by the Hb degradation and LDL peroxidation products, respectively, suggest that not only the extracellular reactions and toxic species but also the cellular signaling pathways clearly differ between these two principal mechanisms of Hb toxicity.
Hp was also capable of blocking Hb-driven LDL oxidation and thereby being protective against this second ('extrinsic') mechanism of Hb-driven endothelial damage. Therefore, the cumulative protective activity of Hp is related to Hp's ability to stabilize the globin structure and to 'shield' transition of oxidation equivalents from Hb to other molecules. 11, 33 In the absence of strong protective mechanisms, such as Hp, oxidative side reactions of extracellular Hb could ultimately link tissue destruction, bleeding, local hemolysis, and oxidative stress to accelerated inflammation and tissue damage. Our studies provide now the first experimental evidence that Hp can act as a molecular switch, which alters the peroxidative reaction of Hb away from pro-inflammatory and cytotoxic toward a protective function.
Materials and Methods
Endothelial cell culture models. All primary human endothelial cells and the respective cell culture media were from Lonza (Basel, Switzerland). Cells were cultured for a maximum of six passages. The following types of Hb were used throughout the studies: (1) stroma-free human Hb (HbA0, huHb), which was catalase depleted by DAEA chromatography. (2) Catalase-free ultrapure bvHb. (3) DBBFaXLHb, both of which were provided by Dr. Abdu Alayash, FDA. Hb/H 2 O 2 experiments were performed with either 2.5 mU/ml (low GOX activity) or 20 mU/ml GOX (high GOX activity; from Sigma Chemical Co., St. Louis, MO, USA) as indicated. Hb was used at 2 mg/ml (ferrous Hb) and glucose was used at 4 g/l. All experiments were performed in complete culture medium (i.e., containing 2% fetal calf serum and without phenol red). Electrical resistance of the endothelial cell monolayers was measured in real time with an electric cell-substrate impedance sensing (ECIS) Z Theta instrument (ibidi GmbH, Planegg/Martinsried, Germany) that used eight-well disposable electrode arrays (8W10 þ ). ECIS software version 1.2.52 was used to operate the instrument and for the subsequent data modeling and analysis. Figure 7 Schematic summary of Hb-catalyzed oxidative endothelial damage and protection by Hp. Graphical illustration of the principal Hb toxicity and Hp protection pathways described in this study. We propose that Hp protects against peroxidative Hb toxicity by stabilizing the Hb structure (mechanism 1) and by shielding extrinsic molecules against Hb/heme-mediated peroxidative damage (mechanism 2) culture medium under conditions identical to those of the cell culture itself (37 1C). Full spectra were recorded every 3 min and deconvoluted to calculate the concentrations of the different reaction species. 34 For the evaluation of aggregate formation, the reactions were continuously measured at 700 nm. For electron paramagnetic resonance (EPR) spin-trapping experiments, the same reactions were performed in the presence of the spin trap DEPMPO (10 mM). During the reaction, samples were measured sequentially in a Bruker ElexSys E500 @9.6 GHz X-band cw spectrometer (Bruker BioSpin AG, Faellanden, Switzerand).
Hb-Hpx heme transfer. MetHb (Fe 3 þ ) of the indicated Hbs was incubated (10 mM in phosphate-buffered saline (PBS) pH 7.4) with a twofold molar excess of Hpx (from Athens Research and Technology, Inc., Athens, GA, USA). Serial UV-VIS spectra were recorded with a Cary 60 UV-VIS Spectrophotometer (Agilent Technologies) and deconvoluted to follow the transition of metHb to heme-Hpx spectra.
LDL peroxidation assay. Human plasma-derived LDL was a kind gift of Dr. Lucia Rohrer, Institute of Clinical Chemistry, University Hospital of Zurich, Zurich, Switzerland. The oxidation of LDL (0.1 mg/ml in PBS, pH 7.4) was measured in a closed, stirred microrespiration system with a Clark-type oxygen electrode (Unisense, Aarhus, Denmark) at 37 1C after the injection of Hb in the Fe 3 þ form (final Hb concentration was 10 mM heme).
Quantitative real-time RT-PCR. RT-PCR has been performed as described. 35 Sequence-specific primers were as follows: HO-1 fwd Gene expression microarray experiments and data analysis. After washing and lysing the cells with buffer RLT, total RNA was isolated using the RNeasy Mini Kit according to the manufacturer's instructions, which included an on-column DNA digestion step (RNase-Free DNase Set, Qiagen Hombrechtikon, Switzerland). To ensure that only high-quality RNA (RNA integrity number47.0) was used for gene expression analysis, each RNA sample was checked on a RNA Nanochip with a Bioanalyzer 2100 (Agilent Technologies). RNA was quantified spectrophotometrically with a NanoDrop ND-1000 spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA). Fluorescently labeled cRNA was generated from 500 ng total RNA with the Quick Amp Labeling Kit (Agilent Technologies) according to the manufacturer's protocol, and differential gene expression profiling was performed by competitive dual-color hybridization on Whole Human Genome Oligo Microarrays (G4112F, 4 Â 44 K, 60-mer, Agilent Technologies). Array slides were XDR scanned and analyzed with Feature Extraction Software Version 10.7.3.1 (Agilent Technologies). Statistical analysis and visualization was performed with JMP Genomics 5.0 (SAS Institute, Boeblingen, Germany). Full gene array data were submitted to gene expression omnibus (GEO Accession #: GSE46471).
